Fig. 2From: End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbationOpioid use for dyspnea in patients with AE-IPF. (A) Proportion of opioid use for dyspnea in patients with AE-IPF (n = 539) and the timing of opioid administration in AE-IPF patient with opioid use (n = 361). (B) Type of opioid used for dyspnea in AE-IPF patients AE: acute exacerbation; IPF: idiopathic pulmonary fibrosisBack to article page